KAZZ MARSEY: Open Payments
NPI 1669132569 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,825 in 93 payments from 29 companies in 2025. Trend: 2023 $2,589 · 2024 $2,380 · 2025 $1,825
Food & beverage: $1,825
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $431 |
| Lilly USA, LLC | 13 | $219 |
| PFIZER INC. | 10 | $155 |
| Ardelyx, Inc. | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| ABBVIE INC. | 4 | $71 |
| Grifols USA, LLC | 3 | $69 |
| Corcept Therapeutics | 2 | $54 |
| TOLMAR, INC. | 2 | $50 |
Products named: Wegovy, MOUNJARO, Ozempic, IBSRELA, JARDIANCE, NURTEC ODT, Kerendia, Prolastin-C Liquid.
Industry payments across MO — which companies pay providers there.
